STOCK TITAN

ORPEA: Information Following the Publication of Press Articles in French Newspaper Le Monde

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

ORPEA (Euronext: ORP) has expressed concern over the premature disclosure of parts of a report by the Inspection Générale des Affaires Sociales (IGAS) and Inspection Générale des Finances (IGF) by Le Monde. The company states that the deadline for submitting its observations has not yet passed, emphasizing that the published sections do not influence the final report's conclusions. ORPEA plans to submit detailed observations to the inspectors and reiterates its commitment to learn from current external evaluations.

Positive
  • Reiterates commitment to transparency and learning from evaluations.
  • Plans to submit detailed observations to IGF-IGAS inspectors.
Negative
  • Concerns over premature publication of inspection report parts may impact investor confidence.

PUTEAUX, France--(BUSINESS WIRE)-- Regulatory News:

ORPEA (Paris:ORP) deplores the disclosure by Le Monde of parts of the report made by the IGAS and the IGF (IGAS, standing for: Inspection Générale des Affaires Sociales, and IGF, standing for: Inspection Générale des Finances) even though the period granted to ORPEA to produce its observations has not yet expired.

As the contradictory phase is not yet over, the parts published today do not in any way prejudge the final conclusions that will appear in the report of the joint IGF – IGAS inspection mission.

ORPEA will provide the IGF-IGAS inspectors with its detailed observations tonight.

ORPEA reiterates its full commitment to communicate and draw all the learnings from the two external evaluations, currently underway, conducted by renowned independent firms.

About ORPEA (www.orpea-corp.com)

Founded in 1989, ORPEA is one of the world leaders in Dependency care (nursing homes, assisted living, post-acute and rehabilitation hospitals, mental health hospitals, home care services).

ORPEA is listed on Euronext Paris (ISIN code: FR0000184798) and is a member of the SBF 120, STOXX 600 Europe, MSCI Small Cap Europe and CAC Mid 60 indices.

Investor Relations

ORPEA

Steve Grobet

EVP Communication and Investor Relations

s.grobet@orpea.net

Benoit Lesieur

Investor Relations Director

b.lesieur@orpea.net

Investor Relations

NewCap

Dusan Oresansky

+33 (0)1 44 71 94 94

orpea@newcap.eu

Media Relations

Image 7

Laurence Heilbronn

+33 (0)6 89 87 61 37

lheilbronn@image7.fr

Charlotte Le Barbier

+33 (0)6 78 37 27 60

clebarbier@image7.fr

Source: ORPEA

FAQ

What did ORPEA state about the IGAS and IGF report?

ORPEA expressed concern over the publication of parts of the report by Le Monde, stating that the deadline for their observations has not yet expired.

How is ORPEA responding to the inspection report?

ORPEA plans to provide IGF-IGAS inspectors with detailed observations regarding the report.

When will ORPEA's full observations be submitted?

ORPEA will submit its full observations to the inspectors tonight.

What is ORPEA's commitment regarding the inspection evaluations?

ORPEA reiterates its commitment to transparency and to drawing lessons from the ongoing evaluations.

Orpea SA

OTC:ORRRY

ORRRY Rankings

ORRRY Latest News

ORRRY Stock Data

371.54M
42.42k
Medical Care Facilities
Healthcare
Link
France
Puteaux